| Table 3. Effect of ATRA on spermatogenesis indices in the ipsilateral testis following TD | |||||
| Groups | Spermatogonia | Spermatocyte | Spermatid | Sertoli | Leydig |
|---|---|---|---|---|---|
| 59.00±0.41 | 77.75±0.85 | 58.00±0.82 | 16.75±0.48 | 198±1.11 | |
| 1.500±0.96a | 3.750±2.18a | 3.250±1.89a | 3.250±0.25a | 33.25±0.95a | |
| 40.00±4.98b | 56.25±6.29b | 44.00±3.24b | 13.75±1.315b | 169.0±4.00b | |
| 4.250±1.89c | 5.500±3.202c | 5.000±2.92c | 2.750±0.250c | 27.00±0.707c | |
Data are presented as mean±SEM (n=6).
Spermatogonia count: a significant decrease (p<0.001) compared with the sham group; b significant increase (p<0.001) compared with the TD group; c significant decrease (p<0.001) compared with the ATRA+TD group.
Spermatocyte count: a significant decrease (p<0.001) compared with the sham group; b significant increase (p<0.001) compared with the TD group; c significant decrease (p<0.001) compared with the ATRA+TD group.
Spermatid count: a significant decrease (p<0.001) compared with the sham group; b significant increase (p<0.001) com-pared with the TD group; c significant decrease (p<0.001) compared with the ATRA+TD group.
Sertoli cell count: a significant decrease (p<0.001) compared with the sham group; b significant increase (p<0.001) com-pared with the TD group; c significant decrease (p<0.001) compared with the ATRA+TD group.
Leydig cell count: a significant decrease (p<0.001) compared with the sham group; b significant increase (p<0.001) com-pared with the TD group; c significant decrease (p<0.001) compared with the ATRA+TD group.